{"acute graft versus host disease": 59.49, "acute graft versus host disease in intestine": 183.62, "acute graft versus host disease in skin": 278.76, "anaemia": 4.29, "aplastic anaemia": 27.66, "cystitis haemorrhagic": 47.11, "cytomegalovirus infection reactivation": 98.96, "deafness": 10.2, "febrile neutropenia": 24.4, "focal nodular hyperplasia": 1031.9, "graft versus host disease in gastrointestinal tract": 204.24, "haematotoxicity": 36.21, "hepatotoxicity": 29.11, "leukopenia": 2.84, "mucosal inflammation": 93.03, "myelosuppression": 3.92, "nervous system disorder": 21.84, "neutropenia": 11.69, "off label use": 3.19, "platelet count decreased": 2.54, "product use in unapproved indication": 3.17, "sepsis": 5.2, "stomatitis": 4.85, "thrombocytopenia": 10.61, "venoocclusive liver disease": 67.79, "visual impairment": 3.76}